SciTech Development LLC
🇺🇸United States
Phase 1 Trial of ST-001 NanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
Phase 1
Recruiting
- Conditions
- Cutaneous T-cell LymphomaSézary's DiseaseCutaneous/Peripheral T-Cell LymphomaPeripheral T-cell LymphomaPrimary Cutaneous T-cell LymphomaCutaneous T-Cell Lymphoma, UnspecifiedAngioimmunoblastic T-cell LymphomaT-cell LymphomaPeripheral T-Cell Lymphoma, Not ClassifiedFollicular T-Cell Lymphoma
- Interventions
- First Posted Date
- 2020-01-21
- Last Posted Date
- 2025-03-26
- Lead Sponsor
- SciTech Development, Inc.
- Target Recruit Count
- 46
- Registration Number
- NCT04234048
- Locations
- 🇺🇸
Mayo Clinic Arizona, Scottsdale, Arizona, United States
🇺🇸City of Hope Medical Foundation, Duarte, California, United States
🇺🇸University of Southern California, Los Angeles, California, United States
© Copyright 2025. All Rights Reserved by MedPath